Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Plebanski

Showing results (111-120 of 219) with videos related to

Pageof 22
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian CancerAmy L Wilson, Laura R Moffitt, Nadine Duffield, et al.
Methods (San Diego, Calif.)|September 26, 2006
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicityMartha Kalkanidis, Geoffrey A Pietersz, Sue D Xiang, et al.
Journal of Oncology|June 27, 2019
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer ImmunotherapyMohammad A I Al-Hatamleh, Suhana Ahmad, Jennifer C Boer, et al.
ACS Biomaterials Science & Engineering|April 11, 2022
Low-Temperature Synthesis of Hollow β-Tricalcium Phosphate Particles for Bone Tissue Engineering ApplicationsIman Roohani, Young Jung No, Betty Zuo, et al.
Vaccine|January 23, 2002
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimesSarah C Gilbert, Jörg Schneider, Carolyn M Hannan, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Vaccine|October 21, 2006
Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacyGabriela Minigo, Anja Scholzen, Choon K Tang, et al.
Frontiers in Immunology|February 12, 2019
Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic ModulationApriliana E R Kartikasari, Monica D Prakash, Momodou Cox, et al.
Advanced Healthcare Materials|July 1, 2023
Smart Nanozymes for Cancer Therapy: The Next Frontier in OncologyNavya P N, Sunil Mehla, Amrin Begum, et al.
Immunology and Cell Biology|May 10, 2005
Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responsesMagdalena Plebanski, Carolyn M Hannan, Shahriar Behboudi, et al.
Pageof 22

Showing results (111-120 of 219) with videos related to

Sort By:
Pageof 22
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian CancerAmy L Wilson, Laura R Moffitt, Nadine Duffield, et al.
Methods (San Diego, Calif.)|September 26, 2006
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicityMartha Kalkanidis, Geoffrey A Pietersz, Sue D Xiang, et al.
Journal of Oncology|June 27, 2019
A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer ImmunotherapyMohammad A I Al-Hatamleh, Suhana Ahmad, Jennifer C Boer, et al.
ACS Biomaterials Science & Engineering|April 11, 2022
Low-Temperature Synthesis of Hollow β-Tricalcium Phosphate Particles for Bone Tissue Engineering ApplicationsIman Roohani, Young Jung No, Betty Zuo, et al.
Vaccine|January 23, 2002
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimesSarah C Gilbert, Jörg Schneider, Carolyn M Hannan, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Vaccine|October 21, 2006
Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacyGabriela Minigo, Anja Scholzen, Choon K Tang, et al.
Frontiers in Immunology|February 12, 2019
Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic ModulationApriliana E R Kartikasari, Monica D Prakash, Momodou Cox, et al.
Advanced Healthcare Materials|July 1, 2023
Smart Nanozymes for Cancer Therapy: The Next Frontier in OncologyNavya P N, Sunil Mehla, Amrin Begum, et al.
Immunology and Cell Biology|May 10, 2005
Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responsesMagdalena Plebanski, Carolyn M Hannan, Shahriar Behboudi, et al.
Pageof 22